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Abstract  
Lymphoepithelioma-like gastric carcinoma (LELGC),  is a rare type of gastric cancer characterized by a 
carcinoma with intense stromal lymphocytic infiltration. It is one of the histological patterns observed in patients 
with Epstein-Barr virus (EBV)-associated gastric carcinoma. According to the World Health Organisation 
classification of tumors of digestive sysytem 2010, LELGC is a rare type of tubular carcinoma. Although this 
entity is hard to be recognized in the biopsy specimens, pathologists and clinicians should acknowledge this 
subset of gastric cancer because it generally has a better prognosis than other forms of EBV-associated gastric 
carcinomas and conventional gastric carcinomas. This might be due to the fact that the patient's inflammatory 
response may prevent the spread of tumor through the gastric wall and to the lymph nodes or remote organs.(21) 
In order to gain a detailed understanding of this rare disease, we reviewed the literature and report here a recent 
case of epithelioid gastric cancer in a 60 year old male patient presented in our Emergency Department.  
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Introduction 
Gastric cancer is the fourth most common cancer diagnosed and the second leading cause of cancer-related death 
worldwide. In Europe (2012), the highest World age-standardised Open (AS) mortality rates for stomach cancer 
are in Belarus for men and Albania for women.The highest mortality rates are in Eastern Asia , Japan, Korea and 
the lowest in Northern America (World cancer research institute 2008).(1,2) 
Gastric cancer is first described in hieroglyphs and papyruses in Ancient Egypt. The first statistical analysis 
of the incidence and mortality of gastric cancer was done in Verona, Italy, 1760-1809, according to which gastric 
cancer was the most common and deadly cancer. Overall, gastric cancer incidence and mortality have fallen 
dramatically over the past 70 years.(2) It continues to be one of the most important malignant diseases with a 
wide range of geographic, ethnic and socio-economic distribution. Lymphoepithelioma-like carcinoma (LLC) of 
the stomach is a rare and peculiar type of gastric carcinoma that was first described by Watanabe et al in 1976 as 
gastric carcinoma with a lymphoid stroma.(3) The reports in the literature with the synonyms undifferentiated 
carcinoma with lymphoid stroma, gastric Lymphoepithelioma-like carcinoma, or medullary carcinoma all 
describe carcinomas with similar morphology.(4,8) Lymphoepithelioma orginally described in nasopharynx. (3,4) 
 
Case presentation  
SH.B. a 60 year old male patient was admitted at the Emergency Department of “Nene Tereza” University and 
Hospital Center, Tirana, complaining of epigastric pain and gastro-duodenal hemorrhage. For several months, 
the patient complained of epigastric pain, loss of apetite, rectal bleeding and weight loss. The laboratory findings 
appeared altered, with hgb = 8.8 g/dl , HCT=28%, WBC= 14.5 x 109 cells/l (normal range, 4.0–10.0×109 cells/l). 
Stool/occult blood test-positive. Liver and kidney functions normal. After performing the laboratory and imaging 
examinations was diagnosed neoplastic lesion on the greater curvature wall of the gastric body. 
A contrast-enhanced computed tomography (CT) scan of the abdomen was conducted, indicating solid focal 
thickening of the mucosa at the greater curvature wall of the gastric body towards the antrum, infiltrating up to 
1.4 cm. 2 small surrounding lymph nodes correlated with Echo. With discrete loco-regional lymphadenopathy. 
Without evidence of solid hepatic, pulmonary or pelvic lesions. 
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Figure 1. Contrast-enhanced computed tomography scan indicating solid focal thickening of the mucosa at the 
greater curvature wall of the gastric body. 
Figure 2 a,b : The gross examination of the gastrectomy specimen revealed a tumor measuring 3×1.8×1 cm with 
a sizeable ulcer on the greater curvature of the gastric body. 
In the surgical procedure the peritoneal cavity was opened.Ventricular neoformation ulcer-vegetative was 
evidenced at the major curvature .Without evidence of penetrating serosis. Loco-regional lymphadenopathy. No 
metastasis detected at distance. The gross examination of the gastrectomy specimen revealed a patelliform tumor 
measuring 3.0x1.8x1 cm with depression and central ulcer at the greater curvature wall , demarcated by the 
surrounding gastric mucosa. In the transverse sections is noticed  thickening of the gastric wall and infiltration 
by a colour beige lesion that infiltrates the gastric muscular layer and reaches subserosa. In the examination for 
lymphnodes  19 lymphnodes were found in the subserosal tissue and omentum . 
In the histological examination it was noted a malignant neoplasm of epithelial origin, organised in sheets 
and nests of round to polygonal cells with poorly defined cell borders within a dense lymphocytic background 
with diffuse pattern or organized in follicles with germinal centers. The epithelial tumor cells are mainly 
organized in small, irregular groups and rarely in larger solid groups. No vascular or lymphatic invasion was 
observed. The tumor infiltrates up to the subserozal tissue. None of the 19 dissected lymph nodes showed 
metastasis. 
 
Figure 3: Hematoxylin-eosin staining of biopsy specimens (a,b, c, d) and Immunohistochemical staining (g, i, h, 
j). 
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The tumor cells showed positive stain for p53, EMA , EBV, Moc 31, and negative immunoreactivity was 
noticed for CK7, CEA , CK20. The association with EBV is based on the uniform expression of EBV in all 
tumor cells while absent in normal epithelium, dysplastic lesions.(30) p53 showed strong and diffuse positivity in 
the tumor cells, suggestive of P53 mutations. 
 
Discussion  
The lymphoid stroma in lymphoepithelioma-like gastric carcinomas can be so pronounced that the lesion can be 
mistaken for an intense reactive lymphoid infiltrate only or even a lymphoma, justifying its designation as a 
lymphoepithelioma-like carcinoma. However, careful search for atypical epithelial cells intimately intermixed 
with the lymphoid cells will allow for the correct diagnosis to be made. In the event that cancer cells are scarce, 
special stains will be of help. The demonstration of cytoplasmic mucin in the large epithelioid cells favors 
carcinoma over reactive macrophages. Differential diagnosis often is made with  : poorly differentiated 
adenocarcinoma, metastasis from naso-pharyngeal carcinoma, lymphoma (Large B-Cell Lymphoma), 
neuroendocrine tumor, GIST, malignant melanoma or medullary carcinoma. 
Histopathologic analysis findings such as: The presence of small solid groups of neoplastic epithelial cell 
without glanduloid organization, dense lymphocitic stroma sparsed or organised in follicles with germinating 
centers, accompanying the lesion, clear demarcation of the lesion from the sorroundig mucosa in the 
macroscopic examination, lack of displastic changes in the sorrounding gastric mucosa, positive 
immunoreactivity for EBV in the site of tumor, p53  diffusely and strongly overexpressed in the tumor cells, 
suggestive of P53 mutations. and positivity stain for EMA,  suggest the diagnosis:"Lymphoepithelioma-like 
gastric carcinoma" (T3N0M0 according to TNM, Stage IIA) WHO classification of tumors 2010 (28) 
LELGCs are defined as tumors which possess histologic similarity to nasopharyngeal carcinoma .(29) 
LELGC of the stomach is a rare type of gastric carcinoma that was first described by Watanabe et al as gastric 
carcinoma with a lymphoid stroma.(3) The stroma consists of CD8- or CD4-positive T lymphocytes, and CD68-
positive macrophages, in a ratio of 2:1:1 and EBV infection is observed only in a very limited number of these 
infiltrating lymphocytes .(16) There are different reports in the literature with the synonyms undifferentiated 
carcinoma with lymphoid stroma, gastric Lymphoepithelioma-like carcinoma, or medullary carcinoma all 
describe carcinomas with similar morphology.(4,8,31) LELGC is also known as EBV-associated gastric carcinoma. 
An etiologic association with EBV is based on the uniform expression of EBV in all tumor cells while absent in 
normal epithelium, dysplastic lesions and lymphoid cells.(30) The mechanism by which EBV contributes to 
carcinogenesis in gastric mucosa is still unknown . EBV-positive gastric LLC has been confirmed to be 
composed of a monoclonal proliferation of a single EBV-infected progenitor cell. (16)This has strongly suggested 
that EBV infects the gastric mucosa before neoplastic transformation and is involved in the early stage of gastric 
carcinogenesis .In a study of 365 cases of gastric neoplasia removed surgically in 1989, 6 of them were 
diagnosed as LELGC.The histologic criteria proposed by Hamazaki for distinguishing this carcinoma were 
intercellular edema and lymphoid cell in- filtration of the tumor parenchyme;  lymphoid feature of the tumor 
stroma; uniformity in distribution of these elements within the tumor. Since the number of cases diagnosed with 
LELGC was too small to provide a base for this special category,  this criteria were not precise enough to be 
adopted universally for the identification of this tumor, anyway they are important because they help the 
pathologists for the accurate differential diagnoses. In a study conducted in Korea 2005 -2012 in a group of 18 
patients diagnosed with LELGC  Tak et al (26) compared the clinical characteristics and prognostic factors 
between gastric LELGC and gastric adenocarcinoma, and found that postoperative recurrence or metastasis 
tended to occur less frequently in gastric LELGC compared with poorly-differentiated gastric adenocarcinoma. 
Among prognostic factors, only the number of lymph node metastases exhibited a significant difference, with 
gastric LELGC being associated with a smaller number of lymph node metastases. The disease-free and overall 
survival rates of gastric LELGC were higher compared with those of poorly-differentiated gastric 
adenocarcinoma. 
 
Conclusions  
Lymphoepithelioma-like gastric carcinoma is a rare subtype of gastric carcinoma with a better survival rate than 
other gastric cancers.(21) Clinically it is similar to gastric cancer, with no obvious early symptoms. 
Lymphoepithelioma-like gastric carcinoma is difficult to discern from biopsy specimens because of the stromal 
lymphocyte infiltrates. As preoperative diagnosis is difficult and it is easily misdiagnosed. The diagnosis of 
lymphoepithelioma-like gastric carcinomas should mainly rest on the characteristic morphology and 
demonstration of EBV using different techniques. By using EBV-encoded RNA in situ hybridization, which is 
now considered to be the most sensitive method for detecting EBV in paraffin-embedded tissues, viral RNA can 
be demonstrated easily. It is considered to be the gold standart in the diagnosis of LELGC.  In spite, pathologists 
and clinicians should acknowledge this subset of gastric cancer because it generally has a better prognosis than 
other forms of EBV-associated gastric carcinomas and conventional gastric carcinomas. Pathologists and 
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clinicians should take into consideration this subset of gastric cancer to make an accurate diagnosis and select the 
appropriate treatment. 
 
Bibliography  
1. American Cancer Society.Global Cancer Facts & Figures 3rd Edition.Atlanta: American Cancer Society; 
2015. 
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 
3. Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and 
prognostic correlations. Cancer. 1976 
4. Horiuchi K, Mishima K, Ohsawa M, Aozasa K. Carcinoma of stomach and breast with lymphoid stroma: 
localisation of Epstein-Barr virus. J Clin Pathol. 1994 
5. Herath CH, Chetty R. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma. Arch Pathol 
Lab Med. 2008 
6. Aurilio G, Ricci V, De Vita F, Fasano M, Fazio N, Orditura M, Funicelli L, De Luca G, Iasevoli D, Iovino F, 
et al. A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC) 
7. Sashiyama H, Nozawa A, Kimura M, Nomura E, Tamaru JI, Ninomiya E, Koide Y, Iino M, Ozawa K. Case 
report: A case of lymphoepithelioma-like carcinoma of the oesophagus and review of the literature. J 
Gastroenterol Hepatol. 1999 
8. Chetty R. Gastrointestinal cancers accompanied by a dense lymphoid component: an overview with special 
reference to gastric and colonic medullary and lymphoepithelioma-like carcinomas. J Clin Pathol. 2012 
9. Bildirici K, Ak G, Peker B, Metintaş M, Alataş F, Erginel S, Uçgun I. Primary lymphoepithelioma-like 
carcinoma of the lung. Tuberk Toraks. 2005 
10. Chen PC, Pan CC, Hsu WH, Ka HJ, Yang AH. Epstein-Barr virus-associated lymphoepithelioma-like 
carcinoma of the esophagus. Hum Pathol. 2003 
11. Grogg KL, Lohse CM, Pankratz VS, Halling KC, Smyrk TC. Lymphocyte-rich gastric cancer: associations 
with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod Pathol. 2003 
12. Gulley ML, Amin MB, Nicholls JM, Banks PM, Ayala AG, Srigley JR, Eagan PA, Ro JY. Epstein-Barr virus 
is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the 
urinary bladder. Hum Pathol. 1995 
13. Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-
positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009 
14. Liang Y, Wang L, Zhu Y, Lin Y, Liu H, Rao H, Xu G, Rong T. Primary pulmonary lymphoepithelioma-like 
carcinoma: fifty-two patients with long-term follow-up. Cancer. 2012 
15. Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. Clinicopathological and molecular characteristics of 
Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009 
16. Fukayama M, Ushiku T. Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract. 2011 
17. Liu S, Jin L, Xu X, Lin N, Lei B, Shen H. Pathological and computed tomography findings of 
lymphoepithelioma-like gastric carcinoma with epithelioid granulomas: A case report. Oncol Lett. 2013 
18. Tamura T, Hamada T, Sako T, Makihara K, Yamada K, Kashima K, Yokoyama S, Hirata K, Hachiya Y, 
Fukuyama T, et al. Lymphoepithelioma-Like Carcinoma of the Stomach with Epithelioid Granulomas. Case 
Rep Gastroenterol. 2010 
19. 18.Leung SY, Chau KY, Yuen ST. et al. p53 overexpression is different in Epstein-Barr virus–associated and 
Epstein-Barr virus–negative carcinoma. Histopathology. 1998 
20. Fukayama M, Chong JM, Kaizaki Y. Epstein-Barr virus and gastric carcinoma. Gastric Canc. 1998 
21. Kijima Y, Ishigami S, Hokita S. et al. The comparison of the prognosis between Epstein-Barr virus (EBV)–
positive gastric carcinoma and EBV-negative ones. Canc Lett. 2003 
22. Beghelli S, de Manzoni G, Barbi S. et al. Microsatellite instability in gastric cancer is associated with better 
prognosis in only stage II cancers. Surgery. 2006 
23. Min KW, Holmquist S, Peiper SC, O'Leary TJ. Poorly differentiated adenocarcinoma with lymphoid stroma 
(lymphoepithelioma-like carcinomas) of the stomach. Report of three cases with Epstein-Barr virus genome 
demonstrated by the polymerase chain reaction. Am J Clin Pathol. 1991 
24. Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson HF, Jr, Cooper PH, Colby TV, Mills SE. 
Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in 
situ hybridization. Am J Surg Pathol. 1989 
25. Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L. EBV DNA in 
biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970 Dec 12  
26. Torlakovic G, Snover DC, Torlakovic E: Simultaneous EBV-positive lymphoepithelioma-like carcinoma and 
EBV-negative intestinal type adenocarcinoma in a patient with Helicobacter pylori–associated chronic 
gastritis. Am J Clin Pathol. 2004,   
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.62, 2018 
 
28 
27. Tak DH, Jeong HY, Seong JK, Moon HS, Kang SH. Comparison of clinical characteristics and prognostic 
factors between gastric lymphoepithelioma-like carcinoma and gastric adenocarcinoma. Korean J 
Gastroenterol. 2013;62:272–277. doi: 10.4166/kjg.2013.62.5.272. (In Korean) 
28. WHO histological classification of gastric tumours 2010 
29. Hiroshi S, Akinori N, Masayuki K. et al. Oesophageal and gastric cancer. J Gastroenterol Hepatol. 
1999;14:534–539. 
30. Beek JV, Hausen AZ, Kranenbarg EK. et al. EBV-positive gastric adenocarcinomas: a distinct 
clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22:664–670. 
doi: 10.1200/JCO.2004.08.061 
31. Minamoto T, Mai M, Watanabe K. et al. Medullary carcinoma with lymphocytic infiltration of the stomach. 
Clinicopathologic study of the subpopulations of infiltrating lymphocytes in the tumor. Cancer. 1990;66:945–
952. doi: 10.1002/1097-0142(19900901)66:5<945::AID-CNCR2820660523>3.0.CO;2-X 
